Related Experiment Video
Updated: May 22, 2026

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
FXR ligands protect against hepatocellular inflammation via SOCS3 induction
Zhizhen Xu1, Gang Huang, Wei Gong
1Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Third Military Medical University, Chongqing 400038, China.
Abstract:
Because of the anti-inflammatory actions of farnesoid X receptor (FXR) agonists, FXR has received much attention as a potential therapeutic target. However, the molecular mechanisms of actions have not yet been elucidated. In the present study, we reported that in the animal model of LPS-induced liver injury, administration of the FXR natural ligand CDCA could attenuate hepatocyte inflammatory damage, reduce transaminase activities, suppress inflammation mediators (IL-6, TNF-α and ICAM-1) expression and inhibit STAT3 phosphorylation. These protective effects of FXR were accompanied by an increased expression of suppressor of cytokine signaling 3 (SOCS3), which is a negative feedback regulator of cytokine-STAT3 signaling. We then demonstrated that the beneficial effects of FXR agonist in STAT3 activation were weakened by small interfering RNA-mediated SOCS3 knockdown in hepacytes. Moreover we observed both natural ligand CDCA and synthetic ligand GW4064 could upregulate SOCS 3 expression by enhancing the promoter activity in hepatocytes. These results suggest modulation of SOCS3 expression may represent a novel mechanism through which FXR activation could selectively affect cytokine bioactivity in inflammation response. FXR ligands may be potentially therapeutic in the treatment of liver inflammatory diseases via SOCS3 induction.
Insights
Farnesoid X receptor (FXR) agonists reduce liver inflammation by increasing suppressor of cytokine signaling 3 (SOCS3) expression. This mechanism may offer new treatments for liver inflammatory diseases.
Area of Science:
- Hepatology
- Molecular Biology
- Immunology
Background:
- Farnesoid X receptor (FXR) agonists exhibit anti-inflammatory properties, making FXR a potential therapeutic target for liver diseases.
- The precise molecular mechanisms underlying FXR's anti-inflammatory actions remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which FXR activation exerts anti-inflammatory effects in liver injury.
- To investigate the role of suppressor of cytokine signaling 3 (SOCS3) in mediating FXR's protective actions.
Main Methods:
- Utilized an animal model of lipopolysaccharide (LPS)-induced liver injury.
- Administered CDCA (a natural FXR ligand) and GW4064 (a synthetic FXR ligand).
- Assessed inflammatory markers, transaminase activities, STAT3 phosphorylation, and SOCS3 expression; employed small interfering RNA (siRNA) for SOCS3 knockdown.
Main Results:
- CDCA administration attenuated hepatocyte inflammatory damage and reduced liver injury markers in LPS-treated mice.
- FXR activation suppressed key inflammation mediators (IL-6, TNF-α, ICAM-1) and inhibited STAT3 phosphorylation.
- These protective effects correlated with increased SOCS3 expression, a negative regulator of cytokine-STAT3 signaling. SOCS3 knockdown diminished FXR's beneficial effects on STAT3 activation. Both natural and synthetic FXR ligands upregulated SOCS3 expression by enhancing its promoter activity.
Conclusions:
- FXR activation protects against liver inflammation, at least partly, through the induction of SOCS3.
- Modulation of SOCS3 expression represents a novel mechanism for FXR's anti-inflammatory effects.
- FXR ligands hold therapeutic potential for treating liver inflammatory diseases by inducing SOCS3.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Regulation of Hematopoietic Stem Cells
TGF - β Signaling Pathway
Cirrhosis II: Pathophysiology
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: